Home

Amgen (AMGN)

337.54
+1.47 (0.44%)
NASDAQ · Last Trade: Nov 22nd, 1:53 AM EST
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
FDA Signs Off On Bayer's New Lung Cancer Drug — Early Results Look Promisingbenzinga.com
FDA grants accelerated approval to Bayer's Hyrnuo and full approval to Amgen's Imdelltra, expanding treatment options for advanced lung cancer.
Via Benzinga · November 20, 2025
Which S&P500 stocks are moving before the opening bell on Thursday?chartmill.com
Before the US market kicks off on Thursday, let's examine the pre-market session and unveil the notable performers among the S&P500 top gainers and losers.
Via Chartmill · November 20, 2025
Q3 Earnings Roundup: Myriad Genetics (NASDAQ:MYGN) And The Rest Of The Therapeutics Segment
Earnings results often indicate what direction a company will take in the months ahead. With Q3 behind us, let’s have a look at Myriad Genetics (NASDAQ:MYGN) and its peers.
Via StockStory · November 18, 2025
Tech Stocks Drop, Pharma Gains As Sector Rotation Picks Up: What's Moving Markets Tuesday?benzinga.com
Wall Street endured another wave of selling in tech stocks on Tuesday, with the Nasdaq 100 down more than 1% by midday in New York, extending its month-to-date slide to more than 5%.
Via Benzinga · November 18, 2025
Check Out What Whales Are Doing With AMGNbenzinga.com
Via Benzinga · November 18, 2025
1 Unpopular Stock That Deserves a Second Chance and 2 We Avoid
Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad things about a company because it can jeopardize their other revenue-generating business lines like M&A advisory.
Via StockStory · November 17, 2025
This Sector Is Suddenly Crushing the Broader Market. Should You Invest $1,000?fool.com
Healthcare stocks have far outperformed the broader market over the past month.
Via The Motley Fool · November 17, 2025
These 2 Dividend ETFs Are a Retiree's Best Friendfool.com
Exchange-traded funds provide investors with exposure to a basket of stocks. Some also pay dividends.
Via The Motley Fool · November 16, 2025
Healthcare Sector Navigates Mixed Market Close: A Beacon of Stability Amidst Uncertainty
As the broader market concluded with a mixed performance on November 14, 2025, the S&P 500 Healthcare sector once again underscored its often-defensive nature, demonstrating resilience amidst an uncertain economic landscape. While specific real-time data for this future date is beyond current predictive capabilities, an analysis of the sector's
Via MarketMinute · November 14, 2025
Fear Of An AI Bubble? This Sector Is Quietly Surging While Tech Sinksbenzinga.com
While AI stocks slide, healthcare is soaring. XLV leads November gains, outperforming tech as investors rotate.
Via Benzinga · November 14, 2025
Why Amgen Stock Edged Past the Market on Thursdayfool.com
The pharmaceutical sector mainstay earned several positive mentions in the pundit sphere that day.
Via The Motley Fool · November 13, 2025
Tech Sector Tremors: Is the AI Bubble Deflating, and What's Next for the Market?
As of mid-November 2025, a palpable unease has settled over the technology sector, long the darling of investors and the primary engine of market growth. After a period of unprecedented outperformance, particularly by companies at the forefront of artificial intelligence (AI), tech stocks are now experiencing a noticeable downturn. This
Via MarketMinute · November 13, 2025
2 Supercharged Dividend Stocks to Buy Nowfool.com
Innovative drugmakers often make for solid dividend stocks. These two companies are great examples.
Via The Motley Fool · November 13, 2025
A Closer Look at Amgen's Options Market Dynamicsbenzinga.com
Via Benzinga · November 13, 2025
Is the Schwab U.S. Dividend Equity ETF the "Ultimate Retirement Fund" for Investors?fool.com
A $10,000 investment in this diversified fund at its 2011 inception would be worth $51,000 today.
Via The Motley Fool · November 13, 2025
Nasdaq Stumbles: Tech Sector Faces Reality Check Amid Valuation Concerns and Sector Rotation
The Nasdaq Composite (NASDAQ: IXIC) experienced back-to-back losses on November 11 and 12, 2025, signaling a significant recalibration in the financial markets. This downturn, primarily driven by growing concerns over stretched valuations in the artificial intelligence (AI) sector and a pronounced rotation of capital into more traditional industries, marks a
Via MarketMinute · November 12, 2025
Dow Jones Soars to Unprecedented Heights as Market Cheers Government Shutdown Resolution
New York, NY – November 12, 2025 – The Dow Jones Industrial Average (DJIA) has shattered previous records, closing at an all-time high of 48,254.82 today, marking a significant milestone for the venerable index. This historic surge, following another record close yesterday, injects a palpable sense of optimism into the
Via MarketMinute · November 12, 2025
Unprecedented Market Anomaly: Gold and Silver Soar as Dow Breaches 48,000 Amidst Inflationary Fears and Geopolitical Tensions
The financial markets are currently exhibiting an extraordinary and complex phenomenon: both traditional safe-haven assets, gold and silver, are experiencing robust rallies, while the Dow Jones Industrial Average (DJIA) has simultaneously surged past the 48,000-point mark. As of November 12, 2025, gold prices are trading around $4,105-$4,
Via MarketMinute · November 12, 2025
Dow Soars Past 48,000 as Gold and Silver Shine in a Market of Paradox
New York, NY – November 12, 2025 – In a remarkable display of market resilience and underlying tension, the Dow Jones Industrial Average (DJIA) has surged past the 48,000-point threshold, closing at an unprecedented 48,015.79. This historic equity rally is unfolding concurrently with a robust ascent in precious metals,
Via MarketMinute · November 12, 2025
Dow Breaches 48,000 Milestone Amidst Government Shutdown Resolution Hopes, S&P 500 and Nasdaq Lag
The Dow Jones Industrial Average (DJIA) made history on Wednesday, November 12, 2025, surging past the 48,000-point mark for the first time ever, gaining nearly 380 points. This significant rally was fueled by a wave of optimism surrounding the imminent resolution of a protracted U.S. government shutdown, which
Via MarketMinute · November 12, 2025
Dow Jones Industrial Average Soars to Record High: A Nuanced Signal for the Economy
NEW YORK, NY – November 11, 2025 – The Dow Jones Industrial Average (DJIA) has reached an unprecedented milestone today, soaring to a new all-time high of 47,927.96, a robust gain of 559.33 points (1.2%). This marks the 16th record close for the index this year, sending a
Via MarketMinute · November 11, 2025
Dow Jones Industrial Average Soars to New All-Time High Amidst Shifting Market Dynamics
New York, NY – November 11, 2025 – The Dow Jones Industrial Average (DJIA) has today surged to an unprecedented all-time high, pushing past significant milestones and reinforcing a complex, yet largely optimistic, sentiment across the financial markets. This monumental achievement signals a robust, albeit cautious, wave of investor confidence, underpinned by
Via MarketMinute · November 11, 2025
Why Amgen Stock Was a Nearly 5% Winner Todayfool.com
The company continued to bask in the glow of a very solid third quarter.
Via The Motley Fool · November 11, 2025
Elevance Health, Labcorp, Privia Health, Fortrea, and Amgen Shares Are Soaring, What You Need To Know
A number of stocks jumped in the afternoon session after the market experienced a sharp sector rotation, as investors fled growth-oriented technology stocks and piled into value-oriented names amid growing valuation concerns. 
Via StockStory · November 11, 2025
Three Healthcare Buys That Wall Street Lovesfool.com
These three healthcare stocks are outperforming most of the sector.
Via The Motley Fool · November 11, 2025